FDA Offers Virtual Visits As Clinical Trial Option

FDA issued a guidance on Wednesday (March 18) offering flexibility around clinical trial policies in a bid to maintain patient safety and test integrity amid the challenges posed by the COVID-19 pandemic, including the possibility of virtual and phone visits for trial participants. Up to now, the agency has generally rejected virtual visits as a trial option, a clinical trial specialist told Inside Health Policy . The agency suggests the alternative assessment methods and offering clinical trial patients losing access...